Italian Study of Patients with Lymphoma (LYMPH-OS)

Scientific Institute for Research Hospitalization and Healthcare (IRCCS)

Status: Enrolling

Conditions: Lymphoma

Study type: Observational

Funder types: Other

Identifiers

NCT06814925

LYMPH-OS

Details and patient eligibility

About

It is an observational, non-interventional, prospective, monocentric study, whose objective is to enroll 1500 patients with lymphoma in 5 years within the Institute of Hematology "Seragnoli".

Full description

The study is aimed at enriching the data on the prognostic role of genetic and epidemiological factors associated with clinical and epidemiological data of patients; to identify factors that influence the evolution of the disease, such as lifestyle and occupational factors, as well as the type of treatment; to document the impact of the disease on quality of life and to provide a platform for future research projects.

Study-specific questionnaires will be administered to patients, both at baseline and during follow-up, which methodologically represent a useful tool in order to achieve these objectives.

Enrollment: 1,500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age greater than or equal to 18 years at enrollment
• Diagnosis of lymphoma within 3 months of enrollment
• Patients may have been treated, as long as the initial diagnosis of lymphoma is within 3 months of enrollment
• Signing of the informed consent form

Exclusion criteria

• none